Your browser doesn't support javascript.
loading
A review of bevacizumab in the treatment of malignant pleural mesothelioma.
Brosseau, Solenn; Assoun, Sandra; Naltet, Charles; Steinmetz, Christelle; Gounant, Valérie; Zalcman, Gérard.
Affiliation
  • Brosseau S; Department of Thoracic Oncology & CIC 1425/CLIP2 Paris-Nord, Bichat-Claude Bernard Hospital, APHP, Paris, France.
  • Assoun S; University Paris-Diderot, Paris, France.
  • Naltet C; Department of Thoracic Oncology & CIC 1425/CLIP2 Paris-Nord, Bichat-Claude Bernard Hospital, APHP, Paris, France.
  • Steinmetz C; Department of Thoracic Oncology & CIC 1425/CLIP2 Paris-Nord, Bichat-Claude Bernard Hospital, APHP, Paris, France.
  • Gounant V; Pharmacy Department, Bichat-Claude Bernard Hospital, APHP, Paris, 46, rue Henri Huchard, 75877 Paris Cedex 18, France.
  • Zalcman G; Department of Thoracic Oncology & CIC 1425/CLIP2 Paris-Nord, Bichat-Claude Bernard Hospital, APHP, Paris, France.
Future Oncol ; 13(28): 2537-2546, 2017 Dec.
Article in En | MEDLINE | ID: mdl-29086616
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Neoplasms / Angiogenesis Inhibitors / Bevacizumab / Antineoplastic Agents, Immunological / Lung Neoplasms / Mesothelioma Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Animals / Humans Language: En Journal: Future Oncol Year: 2017 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Neoplasms / Angiogenesis Inhibitors / Bevacizumab / Antineoplastic Agents, Immunological / Lung Neoplasms / Mesothelioma Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Animals / Humans Language: En Journal: Future Oncol Year: 2017 Document type: Article Affiliation country: Country of publication: